Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein
- Author
- BASTA, Giuseppina1 ; SIRONI, Anna Maria1 ; LAZZERINI, Guido1 ; DEL TURCO, Serena1 ; BUZZIGOLI, Emma1 ; CASOLARO, Arturo2 ; NATALI, Andrea2 ; FERRANNINI, Ele1 2 ; GASTALDELLI, Amalia1
[1] Consiglio Nazionale delle Richerche Institute of Clinical Physiology, University of Pisa School of Medicine, 56124 Pisa, Italy
[2] Department of Internal Medicine, University of Pisa School of Medicine, 56124 Pisa, Italy - Source
The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 11, pp 4628-4634, 7 p ; ref : 38 ref
- CODEN
- JCEMAZ
- ISSN
- 0021-972X
- Scientific domain
- Endocrinology; Nutrition, obesity, metabolic disorders
- Publisher
- Endocrine Society, Bethesda, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Endocrinologie Forme soluble Glycation Glycémie Produit dégradation Protéine Récepteur biologique Stade avancé Calgranuline C
- Keyword (en)
- Endocrinology Soluble form Glycation Glycemia Degradation product Protein Biological receptor Advanced stage Calgranulin C
- Keyword (es)
- Endocrinología Forma soluble Glicación Glucemia Producto degradación Proteína Receptor biológico Estadio avanzado
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A28 Vertebrates: endocrinology
- Discipline
- Endocrinopathies Vertebrates : endocrinology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18274651
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1210/jc.2005-2559 
https://dx.doi.org/10.1210/jc.2005-2559
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1210\/jc.2005-2559\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:130:\"Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein\";s:9:\"\u0000*\u0000jtitle\";s:52:\"The Journal of clinical endocrinology and metabolism\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. clin. endocrinol. metab\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"91\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"4628\";s:8:\"\u0000*\u0000epage\";s:4:\"4634\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0021-972X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BASTA\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Giuseppina\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:18:\"SIRONI, Anna Maria\";i:1;s:16:\"LAZZERINI, Guido\";i:2;s:17:\"DEL TURCO, Serena\";i:3;s:15:\"BUZZIGOLI, Emma\";i:4;s:16:\"CASOLARO, Arturo\";i:5;s:14:\"NATALI, Andrea\";i:6;s:15:\"FERRANNINI, Ele\";i:7;s:19:\"GASTALDELLI, Amalia\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCEMAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:130:\"Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:17:\"Endocrine Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1210\/jc.2005-2559\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:130:\"Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein\";s:9:\"\u0000*\u0000jtitle\";s:52:\"The Journal of clinical endocrinology and metabolism\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. clin. endocrinol. metab\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"91\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"4628\";s:8:\"\u0000*\u0000epage\";s:4:\"4634\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0021-972X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BASTA\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Giuseppina\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:18:\"SIRONI, Anna Maria\";i:1;s:16:\"LAZZERINI, Guido\";i:2;s:17:\"DEL TURCO, Serena\";i:3;s:15:\"BUZZIGOLI, Emma\";i:4;s:16:\"CASOLARO, Arturo\";i:5;s:14:\"NATALI, Andrea\";i:6;s:15:\"FERRANNINI, Ele\";i:7;s:19:\"GASTALDELLI, Amalia\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCEMAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:130:\"Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:17:\"Endocrine Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:20:\"10.1210\/jc.2005-2559\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1210\/jc.2005-2559\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:130:\"Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein\";s:9:\"\u0000*\u0000jtitle\";s:52:\"The Journal of clinical endocrinology and metabolism\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. clin. endocrinol. metab\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"91\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"4628\";s:8:\"\u0000*\u0000epage\";s:4:\"4634\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0021-972X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BASTA\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Giuseppina\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:18:\"SIRONI, Anna Maria\";i:1;s:16:\"LAZZERINI, Guido\";i:2;s:17:\"DEL TURCO, Serena\";i:3;s:15:\"BUZZIGOLI, Emma\";i:4;s:16:\"CASOLARO, Arturo\";i:5;s:14:\"NATALI, Andrea\";i:6;s:15:\"FERRANNINI, Ele\";i:7;s:19:\"GASTALDELLI, Amalia\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCEMAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:130:\"Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:17:\"Endocrine Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1210\/jc.2005-2559\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:130:\"Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein\";s:9:\"\u0000*\u0000jtitle\";s:52:\"The Journal of clinical endocrinology and metabolism\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. clin. endocrinol. metab\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"91\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"4628\";s:8:\"\u0000*\u0000epage\";s:4:\"4634\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0021-972X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BASTA\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Giuseppina\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:18:\"SIRONI, Anna Maria\";i:1;s:16:\"LAZZERINI, Guido\";i:2;s:17:\"DEL TURCO, Serena\";i:3;s:15:\"BUZZIGOLI, Emma\";i:4;s:16:\"CASOLARO, Arturo\";i:5;s:14:\"NATALI, Andrea\";i:6;s:15:\"FERRANNINI, Ele\";i:7;s:19:\"GASTALDELLI, Amalia\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCEMAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:130:\"Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:17:\"Endocrine Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
